Correspondence 0001493152-23-008737 from TC BioPharm (Holdings) plc (TCBP, TCBPW) (CIK 0001872812) (TCBPY)

TC BioPharm (Holdings) plc (TCBP, TCBPW) (CIK 0001872812)
Date: March 23, 2023 · CIK: 0001872812 · Accession: 0001493152-23-008737

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-270808

Date

March 23, 2023

Author

TC BIOPHARM (HOLDINGS) PLC

Form

CORRESP

Company

TC BioPharm (Holdings) plc (TCBP, TCBPW) (CIK 0001872812)

Letter

TC BIOPHARM (HOLDINGS) PLC

Maxim 1, 2 Parklands Way

Holytown, Motherwell ML1 4WR

Scotland, United Kingdom

March 23, 2023

VIA EDGAR

United States Securities and Exchange Commission

F Street, N.E.

Washington, D.C. 20549

Attention: Tim Buchmiller

Re: TC BioPharm (Holdings) plc

Registration Statement on Form F-1

File No. 333-270808

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), TC BioPharm (Holdings) plc (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 5:15 p.m., Eastern Time, on Monday, March 27, 2023, or as soon thereafter as possible.

Please notify Stephen Cohen of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (212) 653-8166 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

Very
truly yours,
TC BIOPHARM (HOLDINGS) PLC

Show Raw Text

CORRESP
1
filename1.htm

TC
BIOPHARM (HOLDINGS) PLC

Maxim
1, 2 Parklands Way

Holytown,
Motherwell ML1 4WR

Scotland,
United Kingdom

March
23, 2023

VIA
EDGAR

United
States Securities and Exchange Commission

100
F Street, N.E.

Washington,
D.C. 20549

Attention:
Tim Buchmiller

    Re:
    TC
    BioPharm (Holdings) plc

    Registration
    Statement on Form F-1

    File
    No. 333-270808

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), TC BioPharm (Holdings)
plc (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated
so that it will become effective at 5:15 p.m., Eastern Time, on Monday, March 27, 2023, or as soon thereafter as possible.

Please
notify Stephen Cohen of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (212) 653-8166 as soon as possible as to
the time the Registration Statement has been declared effective pursuant to this acceleration request.

    Very
truly yours,

    TC BIOPHARM (HOLDINGS) PLC

    By:
    /s/
    Bryan Kobel

    Name:
     Bryan Kobel

    Title:
    Chief Executive Officer

SecProbe.io